BPG is committed to discovery and dissemination of knowledge
Retrospective Cohort Study
©The Author(s) 2025.
World J Gastroenterol. Dec 7, 2025; 31(45): 112318
Published online Dec 7, 2025. doi: 10.3748/wjg.v31.i45.112318
Figure 1
Figure 1 Flow chart of inclusion of patients in the study and development of hepatocellular carcinoma. cACLD: Compensated advanced chronic liver disease; HCV: Hepatitis C virus; SVR: Sustained virological response; DAA: Direct-acting antivirals; HCC: Hepatocellular carcinoma; 1-year-EOT: One year after the end of treatment; TE: Transient elastography.


Write to the Help Desk